Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

By Kawamura Masafumi   Eguchi Keisuke   Izumi Yotaro   Yamato Yasushi   Koike Teruaki   Sakaguchi Hirozo   Hada Enjo   Kobayashi Koichi  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 495-501

Springer Publishing Company

Access to resources Recommend Favorite

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial

By Koukourakis M.I.   Kourousis C.   Kamilaki M.   Koukouraki S.   Giatromanolaki A.   Kakolyris S.   Kotsakis A.   Androulakis N.   Bahlitzanakis N.   Georgoulias V.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 838-844

Elsevier

Access to resources Recommend Favorite

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Phase II trial of capecitabine combined with docetaxel in previously treated patients with non-small cell lung cancer: A randomized controlled study

By                        

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 761-766

Spandidos Publications

Access to resources Recommend Favorite

A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer

By Bennouna J.   Monnier A.   Riviere A.   Milleron B.   Lemarie E.   Trillet-Lenoir V.   Soussan-Lazard K.   Berille J.   Douillard J.Y.  

European Journal of Cancer, Vol. 36, Iss. 9, 2000-06 ,pp. : 1107-1112

Elsevier

Access to resources Recommend Favorite